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An oxygen-sensitive toxin–antitoxin system
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The Hha and TomB proteins from Escherichia coli form an oxygen-dependent toxin–antitoxin
(TA) system. Here we show that YmoB, the Yersinia orthologue of TomB, and its single
cysteine variant [C117S]YmoB can replace TomB as antitoxins in E. coli. In contrast to other TA
systems, [C117S]YmoB transiently interacts with Hha (rather than forming a stable complex)
and enhances the spontaneous oxidation of the Hha conserved cysteine residue to a -SOxH-
containing species (sulfenic, sulﬁnic or sulfonic acid), which destabilizes the toxin. The
nuclear magnetic resonance structure of [C117S]YmoB and the homology model of TomB
show that the two proteins form a four-helix bundle with a conserved buried cysteine
connected to the exterior by a channel with a diameter comparable to that of an oxygen
molecule. The Hha interaction site is located on the opposite side of the helix bundle.
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A
ntimicrobial resistance is a major threat to global health1.
Bioﬁlms are resistant communities of microorganisms
attached to surfaces and encapsulated in a matrix2,3.
Bioﬁlms are involved in 80% of human bacterial infections4 and
confer antibiotic resistance5.
Oxygen consumption in the bioﬁlm generates oxygen gradi-
ents6,7 and may be linked to bioﬁlm dispersal8. Selective cell
death, for example, in anoxic regions, creates channels that
facilitate nutrient-waste product exchange9–11 and bioﬁlm
dispersion12. Dispersed cells are more susceptible to antibiotics
than those in bioﬁlms, although they are also distinct from
planktonic cells in terms of gene expression and pathogenicity13.
Classical toxin–antitoxin (TA) systems are based on silencing
of a stable toxin by a labile antitoxin that, when inactivated,
releases the toxin, resulting in a reduction in metabolism. TA
systems modulate the generation of persister cells14, phage
inhibition15 and bioﬁlm regulation16.
The Hha/TomB TA system is part of the ﬁrst group of TA
systems identiﬁed in bioﬁlms17. The overexpression of Hha
(haemolysin expression modulating protein) causes cell lysis
and reduction of bioﬁlm formation as well as increases bioﬁlm
dispersal18. An engineered variant of Hha caused nearly
complete bioﬁlm dispersal via cell lysis19,20, and deletion of
hha led to no dispersal of Escherichia coli BW25113 (ref. 20)
corroborating the role of Hha in bioﬁlm dispersal. TomB (toxin
overexpression modulator in bioﬁlms, previously known as
YbaJ) inactivates Hha toxicity18 although the mechanism has
not been elucidated.
Here we report that the TomB antitoxin activity is
oxygen-dependent and that its Yersinia orthologue, YmoB can
replace TomB as the Hha antitoxin. A single cysteine variant
[C117S]YmoB is similarly active in vivo and promotes the
oxidation of the single conserved cysteine of Hha to -SOxH
(sulfenic, sulﬁnic and sulfonic acids) by air in the absence of any
external source of reactive oxygen species. Oxidation of Hha or
the introduction of a negative charge at the position of the
cysteine residue, mimicking the presence of -SOx , causes its
destabilization and results in reduced toxicity.
The three-dimensional (3D) structure and also the Hha
transient interaction site of [C117S]YmoB were determined by
nuclear magnetic resonance (NMR). Relevant structural features
include a buried cysteine residue located close to the Hha-binding
site and connected to the opposite side of the four-helix bundle by
a narrow channel with a width comparable to that of an oxygen
molecule. The built-in oxygen sensor in this TA system may
provide a mechanism for environmental regulation of cell
activity.
Taken together, these observations suggest that Hha/TomB
represent a TA system based on the inactivation of the toxin
(Hha) by oxidation with molecular oxygen mediated by the
antitoxin (TomB).
Results
TomB antitoxin activity is oxygen-dependent. We tested the
hypothesis that the Hha-TomB pair was an oxygen-dependent
TA system by measuring E. coli growth at increasing agitation
rates (Fig. 1). Overexpression of Hha has a toxic effect in minimal
medium, resulting in a decrease of the growth rate and the cell
density in the stationary phase. Growth in rich medium showed
an even higher toxicity18. Simultaneous overexpression of Hha
and TomB in minimal medium results in biphasic growth
gradually evolving from the slow growth rate observed when Hha
is overexpressed in the absence of TomB to the faster growth
observed in the controls not expressing Hha. A signiﬁcant
antitoxin effect of TomB was observed after B4 h, and after 6 h,
cultures overexpressing both Hha and TomB reached the same
cell densities as the controls.
Experiments at the two extreme agitation rates were repeated
while simultaneously measuring oxygen saturation, using an
oxygen-sensitive polarographic electrode (Fig. 1b). Oxygen levels
reﬂect the balance between air uptake, enhanced by fast agitation,
and oxygen consumption by the metabolic activity of the bacteria.
At an agitation rate of 100 r.p.m., the oxygen saturation levels of
the control and HhaþTomB expressing cultures reached a
minimum of 1% while at an agitation rate of 250 r.p.m., the
oxygen levels were always higher than 30%. Oxygen levels
increased when the cultures approached the stationary phase. The
longer lag time for the antitoxin activity at slow agitation rates is
consistent with oxygen being required for TomB activity as an
antitoxin.
At the agitation rate of 250 r.p.m., the oxygen levels of the
cultures overexpressing only Hha were always higher than the
controls, reﬂecting a lower oxygen consumption in the presence
of the toxin. At 100 r.p.m., cultures expressing HhaþTomB or
only Hha reached similar oxygen levels (10% saturation) in late
stationary phase in spite of the fact that the cell density, as
measured by the turbidity at 600 nm, was lower in the cultures
expressing only the toxin. However, in these cultures, the number
of colony forming units (CFU) was lower than in those expressing
also the antitoxin (Supplementary Table 1). These observations
suggest that 10% oxygen saturation is enough to enable TomB
antitoxin activity. Interestingly, the observation that the number
of CFU is higher in the samples overexpressing the two proteins
(HhaþTomB) than in those only expressing Hha rules out the
possibility that the observed toxicity of Hha is only related to the
metabolic stress associated with protein overexpression and
conﬁrms that the toxicity of Hha can be compensated by TomB.
These observations suggest an oxygen-dependent TA mechan-
ism that we investigated in detail by combining chemical biology
and structural studies.
YmoB protects E. coli cells from Hha toxicity. A non-redundant
collection of 250 TomB homologues was obtained by BLAST
search using as a query the TomB sequence from E. coli K-12
strain (D64776). The sequences (Supplementary Fig. 1), repre-
sentative of the YbaJ-superfamily, contain from one to ﬁve
cysteines. Cysteine 18 (in 244 sequences) and a second cysteine
located towards the C-terminus (235/250 sequences) are most
conserved. Attempts to obtain suitable constructs to carry out
structural studies of TomB failed, so we focused on its Yersinia’s
homologue YmoB, which has 58.1% pairwise identity, 73.6%
pairwise similarity and contains the two most conserved cysteines
(C18 and C117, Fig. 2a). Its single cysteine variant [C117S]YmoB
proved suitable for structural determination by NMR, as shown
below.
We ﬁrst explored if YmoB and [C117S]YmoB could function-
ally replace TomB in preventing Hha-associated toxicity in E. coli
in planktonic cells and in bioﬁlms. Planktonic cell cultures
overexpressing Hha and either of the two YmoB variants reached
the same cell density of the controls not expressing Hha or
overexpressing both Hha and TomB (Fig. 2b), although the
antitoxin activity of the YmoB variants showed a longer lag time
than TomB. The C117S substitution had no signiﬁcant effect on
YmoB antitoxin activity in planktonic cells.
Overexpression of Hha causes a fourfold decrease of standard
bioﬁlm formation (Fig. 2c). The co-expression of TomB or YmoB
totally restored bioﬁlm formation, although the C117S variant
was slightly less efﬁcient. Regarding bioﬁlm morphology, Hha
overexpression leads to amorphous bioﬁlms with a higher
percentage of dead cells (Live/Dead cells ratio of 5.6±1.4,
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quantitative analysis by COMSTAT21 software). Instead, when
YmoB was co-expressed, the Live/Dead cell ratio signiﬁcantly
increased to 35.4±8.5 and the bioﬁlm was composed by
microcolonies uniformly spread on the entire surface (Fig. 2d).
Thus, YmoB or [C117S]YmoB can functionally replace TomB as
the Hha antitoxin in E. coli.
[C117S]YmoB enhances Hha oxidation in vitro. Hha has a
single cysteine residue (C18) highly conserved in the Hha-family
of proteins. We hypothesized that the oxygen-dependent anti-
toxin activity of TomB and [C117S]YmoB towards Hha could be
related to the oxidation of this conserved cysteine residue.
In addition to their capacity to form disulﬁde-bonds, cysteine
thiol groups can be oxidized to sulfenic (-SOH), sulﬁnic (-SO2H)
and sulfonic (-SO3H) acids22. Sulfenic acid formation is reversible
but sulﬁnic and sulfonic acid are irreversibly formed and result in
the introduction of a negative charge. Hha has an unusual high
proportion (33%) of charged residues and its structure is highly
sensitive to electrostatic effects23. The additional charge
introduced by cysteine oxidation could destabilize Hha and
prevent its inherent toxicity.
To investigate the effect of YmoB on the oxidation of C18 of
Hha in vitro, we used mass spectrometry. Identical samples of
Hha were incubated in the presence and in the absence of
[C117S]YmoB for 30min. Hha was isolated by size exclusion
chromatography (SEC), digested with trypsin and analysed by
mass spectrometry to identify cysteine-containing peptides in
their reduced and oxidized (-SOxH) forms. Figure 3a shows a
decrease in the reduced form and an increase in the oxidized
forms of Hha in the presence of [C117S]YmoB. The differences
with the untreated Hha samples are statistically signiﬁcant
according to a Student t-test with P¼ 0.03 (for sulfonic acid)
and P¼ 0.02 (reduced and other oxidized forms). Variants of
YmoB in which F111 had been mutated showed no effect
(Fig. 3b). The choice of the phenylalanine mutants was based on
the structural studies described below. Interestingly, even in the
absence of YmoB, Hha contains a signiﬁcant proportion of
peptides with oxidized forms of cysteine suggesting that the effect
of YmoB is to enhance its spontaneous oxidation. The Hha
homologue in Yersinia, the protein YmoA, showed similar
oxidation effects (Supplementary Fig. 2).
A negative charge at the cysteine position destabilizes Hha. We
mimicked the effect of adding a negative charge at the cysteine
position by mutating it to glutamic acid, and we measured the
growth of E. coli Dhha expressing the [C18E]Hha variant. As
controls, we used wild-type Hha and a previously studied C18I
variant24. While [C18I]Hha retains its capacity to act as a toxin,
the presence of a negative charge at this position substantially
reduces the toxicity of the C18E variant (Fig. 4a).
The expression levels of wild type, C18I and C18E variants of
Hha are comparable after 4 h of induction at 37 C (Fig. 4b).
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Figure 1 | TomB antitoxin activity depends on the agitation rate. (a) Growth curves of E. coli K-12 MG1655 Dhha cells harbouring pCA24N-hha and
pBAD30-tomB at (from top to bottom) 100, 150, 200 and 250 r.p.m. agitation rates. Control cultures with no expression of Hha or TomB (squares) were
compared with cultures expressing only Hha (circles) and co-expressing both Hha and TomB (diamonds). Growth curves were measured in triplicate at
37 C in tryptone minimal medium (TMM; 10 g l 1 tryptone and 2.5 g l 1 NaCl). Error bars represent the sample s.d. (b) Growth curves and simultaneous
measurements of the oxygen saturation during culture growth at 150 r.p.m. (top) and 250 r.p.m. (bottom) agitation rates.
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Figure 2 | Yersinia’s YmoB protects E. coli from toxic effect of Hha. All experiments were carried out using E. coli K-12 MG1655 Dhha cells harbouring
pCA24N-hha and pBAD30-tomB, pBAD30-ymoB or pBAD30-ymoB(C117S), at 37 C and in TMM. (a) Sequence alignment of TomB/YmoB proteins.
Asterisks highlight the position of conserved cysteine residues at positions 18 and 117. (b) Growth curves of control cultures with no expression of a TA pair
of proteins (squares) were compared with cultures overexpressing: Hha (circles), Hha and TomB (diamonds), Hha and YmoB (triangles up) or Hha and
[C117S]YmoB (triangles down). Experiments were performed in duplicate, and the error bars are the sample standard deviation. (c) Microtitre plate bioﬁlm
assay. Total bioﬁlm formation was measured at OD540nm and was standardized as OD540nm/OD620nm. Experiments were performed in duplicate, and the
error bars are the sample standard deviation. (d) Representative IMARIS (BITplane, Zurich, Switzerland) images of ﬂow cell bioﬁlm with Hha
overexpression (up) and Hha and YmoB co-expression (down). Dead cells (left) are shown in red and live cells (centre) in green, while superimpositions of
dead and alive cells are shown on the right. OD, optical density.
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Figure 3 | [C117S]YmoB enhances the oxidation of Hha. The bars represent the percentage of peptide spectrum matches (PSM) to the various oxidation
states relative to the total PSM of cysteine-containing peptides in the mass spectra of trypsin-treated samples of Hha. Parallel experiments were performed
by incubating Hha for 30min without any added YmoB variant, or in the presence of (a) [C117S]YmoB, or (b) [F111L,C117S]YmoB or [F111Y,C117S]YmoB.
The experiments were run in triplicate and each sample was analysed in duplicate. The error bars are the standard deviations. Asterisks mark statistically
signiﬁcant deviations according to a Student t-test with P¼0.02. [C117S]YmoB enhanced oxidation of YmoA was measured under different conditions and
is shown in Supplementary Fig. 2.
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However, when [C18E] Hha was overexpressed and puriﬁed, this
variant showed a complex NMR spectrum with low dispersion
and non-uniform peak intensities typical of a denatured protein
(Fig. 4c), while the C18I mutant had been previously shown to be
well folded24. Thus, the introduction of a negative charge at
position 18 destabilizes the structure of Hha. A similar effect had
been previously observed in Hha, when changing the electrostatic
balance by the removal of a negative charge via the substitution
E53Q, which resulted in complete protein denaturation25.
Hha was also treated with hydrogen peroxide in vitro to induce
its oxidation. The NMR spectra of 15N-labelled Hha showed a
clear decrease in intensity over time after the addition of H2O2
(Fig. 4d). The most-affected region is centred in a helical segment
next to the cysteine residue (Fig. 4e). Helix 1 contains a
methionine residue that can also be oxidized. The loss of
intensity indicates a structural change from the native form. A
dynamic molten-globule type structure or soluble aggregates are
two of the obvious possibilities. Dynamic light-scattering
experiments showed no signiﬁcant variation after treatment with
H2O2 suggesting the absence of aggregation (Supplementary
Fig. 3).
Taken together, the in vivo and in vitro results conﬁrm that
YmoB variants or TomB act as antitoxins by enhancing the
inactivation of Hha by oxidation.
3D structure of [C117S]YmoB. To gain molecular level insight
into the role of [C117S]YmoB in the oxidation of Hha, we
decided to determine its 3D structure. No structure of any
member of the YbaJ-superfamily is yet known.
Although the [C117S]YmoB variant provided NMR spectra of
enough quality to complete the backbone assignment
(Supplementary Fig. 4), slow time evolution hindered the
assignment of the side chains associated NOE (Nuclear Over-
hauser Effect) cross-peaks required for structure determination.
Therefore, the suite of NMR experiments needed to determine the
3D structure of [C117S]YmoB were carried out in interleaved
mode using non-uniform sampling and targeted acquisition26.
The 3D structure was determined using 1349 NOE/distance, 198
dihedral angle and 36 hydrogen bond restraints with UNIO’10/
CYANA 2.1 software27–29 and ﬁnal reﬁnement in the presence of
explicit water with CNS 1.2.1 software30,31. Reﬁnement statistics
are summarized in Table 1. The NMR assignment and the
structural models have been deposited in the RCSB PDB with
accession numbers RCSB104115 and 2MN2. Details of the
process, experiments and NMR calculation are presented in the
Supplementary Tables 2 and 3.
Figure 5a shows the superposition of the 20 lowest
energy models, which have a root mean square deviation
considering all backbone heavy atoms of 1.89±0.45 Å,
and 0.87±0.14 Å if only the residues in the a-helices are
compared. [C117S]YmoB forms a compact antiparallel
four-helix bundle connected by ﬂexible loops. A one-turn helix
H5, containing the C117 in the wild-type form, is located at the
C-terminus.
A singular feature of the structure is the location of the isolated
cysteine residue (C18) in helix H1, which is completely buried in
the protein hydrophobic core. Consistently, C18 is completely
inaccessible to iodoacetic acid.
Transient interactions of [C117S]YmoB with Hha and YmoA.
Typical TA pairs form stable complexes masking the toxin.
However, addition of Hha or YmoA did not signiﬁcantly affect
the NMR spectra of 15N-labelled [C117S]YmoB. The NMR
spectra of 15N-labelled Hha or YmoA were also not signiﬁcantly
affected by [C117S]YmoB. Thus, in this case, the toxin (Hha) and
antitoxin (YmoB) components do not form a stable complex.
However, they do interact transiently, which is enough to cause
the chemical inactivation of the toxin.
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This fact could be clearly demonstrated using paramagnetic
relaxation enhancement NMR experiments. When a paramag-
netic centre approaches, even transiently, to speciﬁc nuclei, NMR
signals are strongly broadened due to fast relaxation and the
corresponding decrease in signal intensity is easily measured32.
The native single cysteine residue of Hha was reacted with
1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-methanethio-
sulfonate (MTSL) that incorporates a nitroxide spin label. We
compared the intensities of the signals from individual residues of
15N-labelled [C117S]YmoB in the presence and in the absence of
paramagnetic Hha.
[C117S]YmoB residues perturbed by spin-labelled Hha are
clustered: one of the most perturbed residues is E53 located in
helix 2. Additional affected residues are located in adjacent turns
of the same helix (N49, A56 and S57) and in three consecutive
turns of helix 3 (E77, E78, D81 and Y84) (Fig. 5b and
Supplementary Fig. 5). Of these, N49, E53, A56 and D81 are
absolutely conserved in the YbaJ-superfamily. In addition,
position 77 is always occupied by a negatively charged residue
and position 84 by tyrosine or phenylalanine (Fig. 5d). The
transient interaction of spin-labelled YmoA with [C117S]YmoB
was similarly mapped and affected the same regions
(Supplementary Fig. 5). The conserved E53 residue was mutated
to lysine in TomB. The gene expressing [E53K]TomB or wildtype
TomB were incorporated in the pCA24N-tomB-hha plasmid that
also encodes the hha gene. The plasmids were incorporated into a
Dhha DtomB host and the growth curves were compared. The
strains with [E53K]TomB showed signiﬁcantly higher growth
conﬁrming that the E53 residue is functionally important also in
TomB (Supplementary Fig. 6). The better performance of the
E53K variant suggests an improved antitoxin activity against Hha,
although the possibility that TomB has some residual toxicity that
is reduced in the E53K mutant cannot be ruled out.
A channel provides access to C18 in [C117S]YmoB. A buried
site in the interior of the four-helix bundle where the conserved
C18 residue of YmoB is located is a candidate to be the protein
‘active site’ responsible for the enhanced reaction of Hha with
molecular oxygen. The YmoB C18 residue is located close to the
Hha binding site. However, its buried location raises the question
of how oxygen can reach the cysteine site.
Analysis of the structure of [C117S]YmoB using the DoGSi-
teScorer software33 identiﬁed a shallow pocket on the surface of
[C117S]YmoB formed by K15, E19, F108, F111, S112, G113, I116,
S117 and M120 (Fig. 5c). In some of the NMR structures K15,
E19, F108 and F111 side chains deﬁne a narrow channel that
connects the protein surface with the location of C18. The width
of this channel is comparable to that of an oxygen molecule, and
we hypothesized that it could facilitate its access to the interior of
the four-helix bundle. To test this hypothesis, we mutated F111 of
[C117S]YmoB to leucine and to tyrosine. The NMR spectra of the
two mutants are typical of a well-folded protein and, in the case of
the F111L mutant, chemical shifts are very similar to the wild type
suggesting a very similar backbone structure (Supplementary
Fig. 7). However, these two YmoB variants lost their capacity to
enhance Hha oxidation in vitro (Fig. 3b), in agreement with the
suggested role of phenylalanine side chains in channel formation
and YmoB-enhanced oxidation of Hha.
YmoB cysteines are not essential for YmoB antitoxin activity.
YmoB or [C117S]YmoB at 200mM concentration were incubated
in the presence of air, for 1 day at room temperature with 1:10
dimedone, a speciﬁc reagent for sulfenic acid detection yielding a
stable adduct with a characteristic mass increment, in the pre-
sence and in the absence of 2mM dithiothreitol (DTT). Disulﬁde-
bonded oligomers were separated by SEC and monomeric sam-
ples were then digested with GluC endopeptidase. Samples were
analysed by liquid chromatography coupled to tandem mass
spectrometry to identify peptides containing oxidized cysteine
residues. All possible SOxH oxidized forms were detected
(Supplementary Fig. 8). In addition, the observation of a dime-
done adduct of C117 in wild-type YmoB conﬁrmed the formation
of sulfenic acid. Although sulfenic acid was also detected by the
mass increment of the corresponding peptides, no adduct with
C18 was observed.
In order to test whether YmoB cysteine residues are essential
for the antitoxin activity, we compared E. coli Dhha growth for
cells overexpressing Hha and wildtype YmoB, [C117S]YmoB,
[C18S,C117S]YmoB or no antitoxin (Supplementary Fig. 9).
Strains co-expressing Hha and the cysteine-free YmoB variant
showed a longer lag time than those co-expressing Hha and
YmoB. Even so, the ﬁnal cell density at the stationary phase
reached the same level as in the controls not expressing Hha.
Thus, the presence of cysteines is not essential for the antitoxin
activity of YmoB, although they contribute to make it more
efﬁcient.
Discussion
The four-helix bundle is highly conserved in a set of 250
TomB homologues while the C-terminal region, following helix
H4, shows the largest variability (Fig. 5d and Supplementary
Fig. 1).
Table 1 | NMR constrains and reﬁnement statistics.
NOE restrains (total) 1,349
Intra-residue 541
Inter-residue 808
Sequential 353
Non-sequential 455
Medium range 241
Long range 214
Hydrogen bonds 36
Torsion angle restraints (total) 198
j 99
c 99
Total restraints per residue 13
Total restraints per residue in structured residues* 16
Structure calculation statistics
Violations
Distance constraints (Å) 0.0288±0.0024
Dihedral angle constrains () 0.2968±0.0453
Max. dihedral angle violations () 0.5
Max. distance constraint violation (Å) 5
Average pairwise RMSD (Å) for all atoms
Heavy atoms (Å) 2.62±0.44
Backbone atoms (Å) 1.89±0.45
Average pairwise RMSD (Å) for atoms in structured residues*
Heavy atoms (Å) 1.49±0.12
Backbone atoms (Å) 0.87±0.14
Ramachandran analysis
Most favoured regions 93.1%
Additional allowed regions 6.3%
Generously allowed regions 0.5%
Disallowed regions 0.2%
*Structured Residues were considered the amino acids forming a-helices; K7-G30, A43-K65,
G70-F87, D94-F111, I116- L119, a total of 87 amino acids from 122. NMR, muclear magnetic
resonance; RMSD, root mean square deviation.
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One of the most conserved regions includes cysteine 18 and its
environment: position 15 is exclusively occupied by lysine or
arginine, position 19 is preferentially occupied by glutamic and
aspartic acid and position 17 by leucine, placing C18 in a peculiar
hydrophobic but polarized environment. The hydrophobic
environment is completed by aromatic residues in position 108
(phenylalanine appears in 225/250 sequences) and in position 111
(phenylalanine in 240/250 sequences) forming an access channel
to C18 in [C117S]YmoB (Supplementary Fig. 10).
The residues transiently interacting with Hha and their nearest
neighbours are also highly conserved: E53, N49, A56, E77, E78,
D81, D82 and F84.
Thus, the TA mechanism demonstrated in vivo for Hha/TomB
and that is operative also for the artiﬁcial Hha/YmoB pair is likely
to be a general feature in the entire YbaJ-superfamily. However,
in spite of the large similarities, there are distinct subfamilies that
differ, for example in the number of cysteine residues. In this
respect, TomB and YmoB are not the closest members of the
family but, nevertheless, YmoB could functionally replace TomB
as an antitoxin. We also demonstrated similar oxidation processes
in YmoA, suggesting that a similar TA system may also exist in
Yersinia sp.
A homology model of TomB was built from the structure of
[C117S]YmoB using Modeller34. TomB has four cysteines, in
positions 18, 25, 110 and 124. C110 is located at the end of helix
H4, not far from the location of cysteine 117 in YmoB, and C124,
located at the C-terminus of TomB that extends beyond the end
of YmoB.
TomB cysteines 18 and 25 are located in helix H1 and are both
buried in the interior of the four-helix bundle. Interestingly C18
and C25 are located symmetrically, but in opposite directions,
with respect to the Hha interaction site. The residues ﬂanking
C18 (Leu-18Cys-Glu) and C25 (Asp-25Cys-Leu) form a symme-
trical pattern. The residues surrounding C18 in the 3D structure
of [C117S]YmoB and in the homology model of TomB are
identical.
The conservation of the buried cysteine residues, their location
close to the Hha interaction site, and the fact that C18 in YmoB
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Figure 5 | NMR structure of [C117S]YmoB as a model for TomB structure. (a) Superimposition of 20 lowest energy models. Helical regions (H1: 7–30;
H2: 43–65; H3: 70–87; H4: 94–111; and H5: 116–119) are shown in white and non-structured regions in blue. C18 is coloured yellow. The same colour is used
for H1 in the topological representations. Helices H3 (negatively charged) and H4 (positively charged) are represented in red and blue, respectively.
(b) Surface representation of the residues broadened in the presence of paramagnetically labelled Hha. Those located in helices H2 and H3 are shown
in red. Additional affected residues, (mainly in loops) are marked in orange (see Supplementary Fig. 4). The structures in a,b are rotated 180. Most of the
residues contacting Hha are located in one side of the structure. (c) Expanded view of the pocket and channel deﬁned by conserved residues F108 and F111
(purple), K15 (blue), E19 (red) and S117 (C117 in wild-type YmoB, yellow) connecting the surface with the location of the sulfur atom of C18. M120, also
susceptible to oxidation and close to C117, is shown in orange. The entry of the channel is located in the opposite face from the Hha-binding site. S117 is
occupied by cysteine in the wild-type form of YmoB. (d) Logo representation of the sequence variability within the YbaJ-superfamily. Secondary structure of
[C117S]YmoB is represented. An asterisk highlights residues forming the pocket surrounding C18. Some of the sequences terminate after position 116. The
proportion of sequences that extended to a given position is shown and colour-coded in circles at the C-terminal end of the logo representation.
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experiences similar oxidation processes as those observed in Hha
suggest that this residue may be involved in the oxidation
enhancement mechanism. However, the fact that a variant of
YmoB without any cysteine retained some capacity to act as an
antitoxin indicates that the cysteines of YmoB are not essential.
On the other hand, mutations affecting the channel leading to the
YmoB C18 site prevented the oxidation of Hha. Thus, the
environment around YmoB C18, rather that the cysteine residue
itself is probably sufﬁcient for YmoB-enhanced oxidation,
although the cysteine residue may play a role, for example
through its transient and reversible oxidation to sulfenic acid.
TomB seems to have this site duplicated while the Hha-binding
site is not. These structural variations among the YbaJ super-
family probably reﬂect adaptions to the required levels of
antitoxin activity or their oxygen dependency.
The cysteine residues of Hha and YmoA are partially oxidized
spontaneously by air in vitro even in the absence of TomB or
YmoB giving a mixture of sulfenic, sulﬁnic and sulfonic acid.
However, the oxidation is enhanced in the presence of
[C117S]YmoB. This cysteine residue is conserved in nearly all
members of the Hha family but its function was unknown. It is
located in a loop between to helical regions, only partially solvent
exposed, and located in the interface between regions with
opposite charge35,36. The unusual sensitivity to oxidation may be
related to this particular environment. Interestingly, C18 in
YmoB is also located in a buried region but surrounded by
charged residues.
Reactions of free molecular oxygen have a high-activation
barrier associated with the symmetry of its electron spin triplet
ground state37. The presence of polar residues, electric dipoles or
interactions breaking the local symmetry enhances the capacity of
molecular oxygen to oxidize cysteine to SOxH species22,38.
Hha oxidation leads to a loss of structure thus explaining its
inactivation by TomB in the presence of oxygen. The Hha
structure was also destabilized by a mutation introducing a
negative charge at the position of C18. The sensitivity of Hha to
charge modiﬁcations had been previously observed and is
consistent with its unusual high density of charged residues23,25.
Overall, these results strongly suggest that the TA system
formed by proteins from the Hha-YbaJ superfamily acts through
a mechanism that does not fall in any of the currently accepted
TA classes. While known TA systems are based on a stable toxin
that is neutralized by forming a complex with a labile antitoxin,
the Hha-YbaJ system is based on the chemical inactivation of the
toxin caused by oxidation, enhanced in the presence of the
antitoxin. This process does not require the formation of a stable
TA complex but takes place through transient interactions.
The described mechanism links the TA system to the
concentration of oxygen, making proteins from the YbaJ-
superfamily effective antitoxins only for highly oxygenated cells.
Strong oxygen concentration gradients in bioﬁlms could cause the
antitoxin to be less efﬁcient in cells located in anoxic regions,
resulting in selective death of these cells and the creation of
cavities in the bioﬁlm matrix allowing the escape of planktonic
cells, or detachment of entire microcolonies facilitating bioﬁlm
dispersion.
The structure of [C117S]YmoB provides hints on the chemical
origin of this activity and suggests that the members of the YbaJ-
superfamily could be targets for antibacterial treatments to inhibit
the formation of bioﬁlms, one of the strongest contributors to the
pressing antibiotic resistance problem.
Methods
Antitoxin activity of TomB, and YmoB variants. Growth curves. One colony of
E. coli K-12 MG1655 Dhha cells harbouring pCA24N-hha (under the control of
T5lac promoter, activated by 1mM IPTG (isopropyl b-D-1-thiogalactopyranoside),
selected with 100 mgml 1 of ampicillin) and pBAD30-tomB or pBAD30-ymoB or
pBAD30-ymoB(C117S) or pBAD30-ymoB(C18S)(C117S) (under the control
of araC promoter, activated by 0.1% arabinose, selected with 50 mgml 1 of
chloramphenicol) was pre-cultured overnight at 37 C and 250 r.p.m. in 30ml of
tryptone minimal medium (TMM: 10 g l 1 tryptone and 2.5 g l 1 NaCl).
Growth curves were started by adding 4ml of preculture to 200ml of TMM
(with corresponding antibiotics and chemical inducers) and the experiments were
carried out with the incubators and the room maintained at 37 C.
Oxygen saturation measurements. Dissolved oxygen was measured as the
percentage of saturation using a polarographic electrode (VWR DO210) using the
built-in temperature and ionic-strength compensation. The electrode was cleaned
with 14% ammonium hydroxide for 2min and MilliQ water for 1min to prevent
cross-contamination.
Colony forming unit measurements. The number of CFUs was obtained by
platting 10ml of a 108 dilution of samples taken at selected optical densities.
Microtiter bioﬁlm assays. Single colonies of E. coli K-12 MG1655 Dhha cells
harbouring pCA24N-hha and pBAD30-tomB or pBAD30-ymoB or pBAD30-
ymoB(C117S) were inoculated into 25ml TMM medium (with the corresponding
antibiotic) and incubated overnight at 37 C and 250 r.p.m. shaking speed. Two
independent cultures were prepared for each strain, diluted with fresh TMM
(with the corresponding antibiotic) to obtain an OD600 below 0.05, and 300 ml of
culture were added into separate wells of a 96 well plate. Blanks were prepared with
pure TMM medium. The plate was incubated at 37 C without shaking, for 15 h.
To record the total growth, we measured OD620. Supernatant was discarded and the
plate was washed by dipping three times in MilliQ water, 300ml of 0.1% crystal
violet were added in each well and the plate was incubated for 20min at room
temperature. Staining solution was discarded and the plate was washed by dipping
three times in MilliQ water. An amount of 300ml of 95% ethanol was added to each
well and was incubated for 5min. We measured the total bioﬁlm reading OD540
after mixing for 50 s. Standard bioﬁlm formation was calculated as OD540/(OD620
OD620). OD measurements were done using Inﬁnite M1000 PRO plate reader.
Flow cell bioﬁlm assays. Strain E. coli K-12 MG1655 Dhha pCA24N-hha
pBAD30-ymoB was streaked on LB agar plates with the corresponding antibiotics.
One-day old single colonies were inoculated in 25ml of TMM overnight at 37 C at
250 r.p.m. Overnight cultures were diluted to reach OD600 below 0.05 in 150ml
TMM with the corresponding antibiotics. Diluted cultures under stirring at 37 C
were pumped to the ﬂow cell at 10ml h 1 for 3 h to facilitate cell attachment to the
glass slide surface. Culture medium was replaced with 200ml of fresh TMM
containing the corresponding antibiotics and inducers and then fed to the ﬂow cell
at the same rate for 15 h. After incubation, the ﬂow cell unit was disconnected and
blocked (never allowing it to dry). It was placed at room temperature and the
SYTO9 mix was added using a 5ml syringe. The ﬂow cell was incubated with
SYTO9 in the dark for 20min at room temperature. Eight images in random
positions were taken with an Olympus FV100 confocal microscope using a long
working distance  40 Olympus LWDCDPLAN 40LP lens. 3D images of each spot
were obtained using IMARIS software, and quantitative analysis of bioﬁlm was
performed using COMSTAT software. For the SYTO9 stain preparation, the
LIVE/DEAD BacLight Bacterial Viability Kit L7007 was used. Three millilitre of
dye was prepared in a 30ml glass beaker mixing; 7.5 ml of component A (SYTO
9 dye, 1.67mM / propidium iodide, 1.67mM), 7.5 ml of component B (SYTO 9 dye,
1.67mM / propidium iodide, 18.3mM) and 3ml of TMM.
YmoB mutagenesis. Mutations in YmoB (cysteine to serine, phenylalanine to
leucine, phenylalanine to tyrosine) were introduced using the QuickChange site
directed mutagenesis Kit (Stratagene) with the appropriate complementary
mutagenic primers. We conﬁrmed the constructs by DNA sequencing.
[C117S]YmoB 3D NMR structure.. [C117S]YmoB sample preparation for NMR
experiments. 13C/15N-labelled [C117S]YmoB variant was expressed in E. coli BL21
(DE3) in minimal medium with 15NH4Cl and/D-[13C] glucose as the sole sources
of nitrogen and carbon respectively39. Cells were lysed by sonication. Soluble
protein was puriﬁed by His-Tag afﬁnity chromatography (Ni-NTA agarose
resin QIAGEN) and samples were eluted using buffer A (20mM Trizma
hydrochloride, 800mM NaCl, 400mM imidazole, 5mM DTT and pH¼ 8.00).
Protein was further puriﬁed by SEC using HiLoad Superdex 75 prepgrade
columns (GE Healthcare) and buffer B (pH¼ 7.00 buffered with 20mM
[NaH2PO4þNa2HPO4], 150mM NaCl, 1mM tris-carboxyethylphosphine
(TCEP), 0.1mM ethylenediaminetetraacetic acid (EDTA) and 0.01% w/v NaN3).
Fractions containing the puriﬁed protein were concentrated using a centrifugal
concentrator VIVASPIN 20 10,000 MWCO PES to the mentioned concentrations
for NMR experiments.
NMR acquisition, processing and analysis. NMR spectra listed in Supplementary
Table 2 were acquired at 1.4mM protein concentration, in buffer A and 25 C on
600 or 800MHz Bruker spectrometers equipped with a cryo-pulse-ﬁeld gradient
triple-resonance probe. NMR spectra listed at Supplementary Table 3 were
acquired at 1.0mM protein concentration in buffer B and 25 C on 900 or 800MHz
Agilent spectrometers equipped with a cryo- (900MHz) and room temperature
(800MHz) pulse-ﬁeld gradient triple- resonance probes. Hydrogen bonds were
identiﬁed from a H/D exchange experiment. A lyophilized sample of 1.4mM
[C117S] YmoB was suspended in D2O reaching the same concentration, and a
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two-dimensional 1H-15N-heteronuclear single quantum correlation (HSQC)
experiment was acquired after 4min of sample preparation. Stereospeciﬁc
assignments of valine and leucine methyl groups were obtained from a constant
time 1H–13C HSQC on a 10% 13C/100% 15N [C117S]YmoB 1.4mM sample in
buffer B. One fresh sample of 15N–13C labelled [C117S]YmoB at 1.0mM in buffer
B was used for NOE correlation spectroscopy (NOESY) experiments and an
equivalent fresh sample for total correlation spectroscopy (TOCSY) experiments.
Protein distance restraints were obtained from 3D 1H–15N edited NOESY HSQC,
3D 1H–13C edited NOESY (aromatic optimized in D2O), and 3D 1H–13C edited
NOESY HSQC in D2O experiments. NOESY and TOCSY spectra were recorded
using gradient sensitivity-enhanced pulse sequences from the BioPack library
(Agilent Inc.). Mixing time in NOESY experiments was set to 100ms and to 14ms
in TOCSY experiments. The non-uniform sampling (NUS) schedules were
prepared by program nussampler from the MDDNMR software package40. When
appropriate, the sampling probability density was biased for aliphatic 13C-aliphatic
evolution according to the single-bond 13C–13C homonuclear coupling constant of
35Hz. When appropriate, sampling was exponentially weighted according to the
maximum evolution time. Data processing and analysis were carried out with
MDDNMR, NMRPipe41, NMRViewJ42 and CARA43. Proton chemical shifts were
referenced using 4,4-dimethyl-4-silapentane-1-sulfonic acid as an internal
standard, whereas 15N and 13C chemical shifts were indirectly referenced.
Structure determination. NOE distance restraints were obtained iteratively using
the Unio’10/CYANA 2.1 (refs 27–29) suite program and manually inspected.
Structure was determined by simulated annealing using the torsion angle dynamic
simulation program CYANA 2.1 and further water reﬁnement with CNS 1.2.1
(refs 30,31). Protein structure calculation was based on Unio’10/CYANA generated
upper distances using only unambiguously assigned restraints derived from
NOESY experiments, hydrogen bond restraints based on H/D 1H-15N-HSQC
exchange experiments and dihedral angle restraints calculated with TALOSþ
(ref. 44). An ensemble of 100 protein structures was generated and the 20 lowest
energy models were checked using PROCHECK-NMR45. None of the structures
contained distance or dihedral angle violations 40.5 Å or 5, respectively. Inter-
helical angles were measured with Chimera v10.1 (ref. 46). Ramachandran analysis
is as follows: 93.1% most favoured regions, 6.3% additional allowed regions, 0.5%
generously allowed regions and 2.2% disallowed regions. Molecular images
were generated with Chimera, Gimp (http://www.gimp.org/) and InkScape
(https://inkscape.org/en/). Pocket identiﬁcation was carried out with DogSiteScorer
server33 using default settings. The TomB homology model was built using
Modeller34 starting with YmoB as template structure and only rebuilding
the regions surrounding insertions or deletions in the sequence alignment.
Logo representation was generated using web service from http://weblogo.
threeplusone.com47 and manually coloured using InkScape.
Paramagnetic relaxation enhancement (PRE-NMR) experiments. 15N-labelled
[C117S]YmoB, Hha and YmoA proteins were prepared as previously described for
13C/15N-labelled [C117S]YmoB. For MTSL-protein functionalization, reductant
was ﬁrstly removed using PD10 desalting column (GE). Commercially available
MTSL tag (1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-methanethiosulfonate
from Santa Cruz Biotechnology) was dissolved in acetone and 10 molar equivalents
of MTSL were added to the protein sample and left reacting overnight at 4 C
under stirring conditions. Excess of MTSL was removed using P10 desalting
column in buffer containing 20mM [NaH2PO4þNa2HPO4] pH¼ 7, 150mM
NaCl, 0.1mM EDTA. Protein samples were prepared fresh and measured imme-
diately after preparation. NMR experiments were recorded at 298 K with a
600MHz Bruker Avance III spectrometer equipped with a TCI cryo-probe. NMR
spectra were analysed using CCPNMR Analysis48.
Mass spectrometry. Hha oxidation by [C117S]YmoB. A solution containing
500mM Hha and 500 mM [C117S]YmoB was incubated for 30min in 20mM
[NaH2PO4þNa2HPO4], 150mM NaCl, 0.1mM EDTA pH¼ 7.00. Parallel
experiments were carried out with the same batch of Hha with [F111L,C117S]Y-
moB, [F111Y, C117S]YmoB or without any YmoB variant. Hha and YmoB were
separated by SEC in 50mM ammonium acetate buffer. Hha was digested with
trypsin and the resulting peptides were analysed by nanoHPLC-ESI-MS/MS
(nano high-performance liquid chromatography coupled to tandem mass
spectrometry with nanoelectrospray ionization) in a LTQ-FT Ultra (Thermo
Scientiﬁc) mass spectrometer and processed and analysed with Xcalibur software
(versus 2.02 SR2). Ion deconvolution to zero charged monoisotopic masses was
performed using Xtract algorithm in Xcalibur software.
The relative abundance of the oxidized species was estimated from the ratio of
the peptide spectrum matches (PSM) corresponding to peptides with oxidized
cysteine (sulfenic, sulﬁnic or sulfonic acids) with respect to the PSM number of all
cysteine-containing peptides. The incubation and digestion steps were carried out
at least in duplicate and at least two separate samples of each peptide mixture were
analysed by mass-spectrometry.
In a separate experiment the relative abundance of oxidized peptides was
also calculated considering the chromatographic peak areas of the corresponding
peptides using Skyline 3.1 software49, obtaining equivalent results (data not
shown).
Extended air oxidations of YmoB, [C117S]YmoB and YmoA. YmoB or
[C117S]YmoB at 200 mM protein concentration and YmoA alone or in the pre-
sence of [C117S]YmoB were incubated in the presence of air for 12 days in a
buffered solution of 20mM [NaH2PO4þNa2HPO4] pH¼ 7.0, 150mM NaCl,
0.1mM EDTA and 0.01% w/v NaN3) with or without DTT (2mM) and in the
presence of dimedone in a 1:10 ratio. Peptides were generated with endoproteinase
GluC digestion and analysed as described above.
Toxicity tests of Hha and TomB variants.. Overnight cultures of E. coli BW25113
Dhha harbouring pCA24N, pCA24N-hha, pCA24N-hha(C18E) or pCA24N-hha
(C18I) were inoculated into 25ml of LB medium with 30 mgml 1 chlor-
amphenicol and 1mM IPTG at an OD600 of 0.04. For TomB and [E53K]TomB,
overnight cultures of E. coli ATCC25404 Dhha DtomB harbouring pCA24N-tomB-
hha or pCA24N-tomB(E53K)-hha were inoculated into 25ml of LB medium with
30 mgml 1 chloramphenicol at an OD600 of 0.05. After an hour of inoculation,
0.1mM IPTG was added. Growth was evaluated periodically by measuring OD600.
For each strain, two or three independent cultures were evaluated. To check total
protein expression, cultures at an OD600 of 0.5 were induced with 1mM IPTG for
4 h. Cells were sonicated, centrifuged, and 25 mg of cell lysates (supernatant) were
resolved via 18% SDS–polyacrylamide gel electroporesis. Total protein of cell
lysates was quantiﬁed using the Pierce BCA Protein Assay Kit (Thermo Scientiﬁc,
Waltham, MA).
Stability tests of [C18E]Hha and oxidized Hha. The hha(C18E) mutation was
generated in a pET15b expression plasmid35 that produces a His6-tagged form of
Hha. The 15N-labelled wild type and [C18E] proteins were puriﬁed by His-Tag
afﬁnity chromatography (Ni-NTA agarose resin QIAGEN) by eluting with 20mM
Trizma hydrochloride, 800mM NaCl, 400mM imidazole, 5mM DTT and
pH¼ 8.00. A ﬁnal puriﬁcation step on a Superdex 75 column in 20mM sodium
phosphate, 150mM NaCl, 1mM TCEP, 0.01% w/v NaN3, pH¼ 7.00 yielded pure
proteins as monomers.
Before H2O2 treatment, TCEP was removed by passing the protein solution
through a PD-10 column. After measuring the reference NMR spectra, the
wild-type protein was treated with 5mM H2O2 and spectra were recorded every
130min.
Data availability. All relevant data are available from the authors. NMR assign-
ment and the structural models have been deposited in the RCSB PDB with
accession numbers RCSB104115 and 2MN2.
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